Clinical Trial Update: Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of PD-1 knockout tumor-infiltrating lymphocytes in advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• PD-1 knockout tumor-infiltrating lymphocytes

Snippet

Sponsor: Ruijin Hospital | Conditions: Colorectal Cancer (CRC), Tumor Infiltrating Lymphocytes | Phase 1 | Status: RECRUITING